Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC

Summary by AI ^BETAClose X

Barclays disclosed an open position in Advanced Medical Solutions Group plc comprising 7,970,262 shares (3.61% of voting rights) long and 7,971,038 shares (3.61%) short, with 7,043,926 shares held directly (3.19%) and 927,113 shares short (0.42%). On 03 Nov 2026 Barclays executed net purchases of 30,058 shares (total buys 116,530 at £2.825–£2.830; total sells 86,472 at £2.825–£2.830). The disclosure shows material cash-settled derivative exposures (e.g., 926,336 units = 0.42% and 7,043,925 units = 3.19%) and no stock-settled derivatives, indemnities or concert-party arrangements were reported.

Disclaimer*

Companies

Barclays (BARC)
Advanced Medical Solutions Group (AMS)

UK 100

Latest directors dealings

5 hours ago Luceco
5 hours ago Helios Towers
5 hours ago Wise Class A
6 hours ago EDX Medical Group Plc
6 hours ago Naked Wines

All directors dealings today

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1.				KEY INFORMATION
(a)	Full name of discloser:				Barclays PLC.
(b)	Owner or controller of interest and short
	positions disclosed, if different from 1(a):
(c)	Name of offeror/offeree in relation to whose				ADVANCED MEDICAL SOLUTIONS GROUP PLC
	relevant securities this form relates:
(d)	If an exempt fund manager connected with an
	offeror/offeree, state this and specify identity of
	offeror/offeree:
(e)	Date position held/dealing undertaken:				03 Nov 2026
(f)	In addition to the company in 1(c) above, is the discloser making				NO
	disclosures in respect of any other party to the offer?
2.				POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)	Interests and short positions in the relevant securities of the offeror or offeree
	to which the disclosure relates following the dealing(if any)
Class of relevant security:				5p ordinary
				Interests		Short Positions
				Number	(%)	Number	(%)
(1)	Relevant securities owned
	and/or controlled:			7,043,926	3.19%	927,113	0.42%
(2)	Cash-settled derivatives:
				926,336	0.42%	7,043,925	3.19%
(3)	Stock-settled derivatives (including options)
	and agreements to purchase/sell:			0	0.00%	0	0.00%

	TOTAL:			7,970,262	3.61%	7,971,038	3.61%
(b)	Rights to subscribe for new securities (including directors and other executive
	options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3.				DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
(a)	Purchases and sales
Class of relevant		Purchase/sale		Number of		Price per unit
security				securities
5p ordinary		Purchase		88,247		2.8250 GBP
5p ordinary		Purchase		22,239		2.8300 GBP
5p ordinary		Purchase		6,044		2.8275 GBP
5p ordinary		Sale		82,777		2.8250 GBP
5p ordinary		Sale		2,879		2.8275 GBP
5p ordinary		Sale		816		2.8300 GBP

(b)	Cash-settled derivative transactions
Class of		Product		Nature of dealing		Number of	Price per
relevant		description				reference	unit
security						securities
5p ordinary		SWAP		Increasing Short		2,603	2.8300 GBP
5p ordinary		CFD		Decreasing Long		945	2.8270 GBP
5p ordinary		SWAP		Decreasing Long		29	2.8268 GBP
5p ordinary		SWAP		Closing Long		991	2.8269 GBP
5p ordinary		SWAP		Decreasing Long		3,474	2.8268 GBP
5p ordinary		SWAP		Increasing Short		2,822	2.8250 GBP
5p ordinary		SWAP		Increasing Short		19,194	2.8300 GBP

(c)	Stock-settled derivative transactions (including options)
(i)	Writing, selling, purchasing or varying
Class	Product	Writing,	Number	Exercise	Type	Expiry	Option
of	description	purchasing,	of	price		date	money
relevant		selling,	securities	per unit			paid/
security		varying etc	to which				received
			option				per unit
			relates


(ii)	Exercise
Class of relevant		Product description		Exercising/ exercised against		Number of	Exercise price per
security						securities	unit


(d)	Other dealings (including subscribing for new securities)
Class of relevant		Nature of Dealings		Details		Price per unit (if
security						applicable)

4.				OTHER INFORMATION
(a)	Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b)	Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c)	Attachments
Is a Supplemental Form 8 (Open Positions) attached?				NO
Date of disclosure:				04 Nov 2026
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213

Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC

Summary by AI BETAClose X

Companies

UK 100

Latest directors dealings

Summary by AI ^BETAClose X